Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeWages, Salaries and Other
Others
Ratios

Nu-Med Plus (NUMD) Depreciation & Amortization - Total (2016 - 2021)

Nu-Med Plus' Depreciation & Amortization - Total history spans 10 years, with the latest figure at $2650.0 for Q4 2021.

  • Quarterly results put Depreciation & Amortization - Total at $2650.0 for Q4 2021, changed 0.0% from a year ago — trailing twelve months through Dec 2021 was $9365.0 (down 20.6% YoY), and the annual figure for FY2021 was $9365.0, down 20.6%.
  • Depreciation & Amortization - Total for Q4 2021 was $2650.0 at Nu-Med Plus, roughly flat from $2649.0 in the prior quarter.
  • In the past five years, Depreciation & Amortization - Total ranged from a high of $3803.0 in Q2 2018 to a low of $1417.0 in Q2 2021.
  • The 5-year median for Depreciation & Amortization - Total is $3091.0 (2019), against an average of $3090.6.
  • The sharpest move saw Depreciation & Amortization - Total surged 100.67% in 2017, then plummeted 53.51% in 2021.
  • Year by year, Depreciation & Amortization - Total stood at $3585.0 in 2017, then rose by 5.27% to $3774.0 in 2018, then dropped by 19.55% to $3036.0 in 2019, then decreased by 12.71% to $2650.0 in 2020, then changed by 0.0% to $2650.0 in 2021.
  • According to Business Quant data, Depreciation & Amortization - Total over the past three periods came in at $2650.0, $2649.0, and $1417.0 for Q4 2021, Q3 2021, and Q2 2021 respectively.